Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 474 All time
- Disclosed funding
- $19.6B 401 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| I IntegrantCompany profile Develops integrated solutions across artificial intelligence, medical technology and biologics Develops integrated solutions across artificial intelligence, medical technology and biologics | Undisclosed | Series A | Biotech | Australia | Investors Undisclosed | |
| FT Develops a bispecific antibody to treat anemia of inflammation | $3.5M | Seed | Biotech | Switzerland | Investors | |
| C Provides personalized health plans using causal AI and clinical expertise | $3.3M | Pre-SeedPre-seed | Biotech, Healthtech | United Kingdom | Investors | |
| Q QMatterCompany profile Develops quantum compression technology to enable computation on existing quantum and classical systems Develops quantum compression technology to enable computation on existing quantum and classical systems | $1.2M | Pre-SeedPre-seed | Biotech, Hardware | United Kingdom | Investors | |
| N NephronomicsCompany profile Develops AI-driven precision medicine for cardio-kidney-metabolic disease Develops AI-driven precision medicine for cardio-kidney-metabolic disease | Undisclosed | StrategicUndisclosed | Biotech, Healthtech | United States | Investors | |
| P PlanetaryCompany profile Fermentation infrastructure and technology licensing for producing food ingredients and bio-based materials. Fermentation infrastructure and technology licensing for producing food ingredients and bio-based materials. | CHF 22M | Series A and creditSeries A | Biotech, Foodtech | Switzerland | Investors | |
| U Develops AI-native operating system for preventive and personalized care | $9.3M | Seed | Biotech, Healthtech | United States | Investors | |
| OT Develops antiviral drugs for polyomavirus infections | $11M | Undisclosed | Biotech | United States | Investors Undisclosed | |
| S Develops AI-powered intelligent fermentation systems | $20M | StrategicUndisclosed | Biotech | United States | Investors | |
| TB Terremoto BiosciencesCompany profile Develops highly targeted, small molecule medicines for cancer and rare diseases Develops highly targeted, small molecule medicines for cancer and rare diseases | $108M | Series CSeries C+ | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1RA Capital Management
Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology
22rounds3led - 2Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
15rounds1led - 3Eli Lilly and Company
BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences
15rounds0led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
14rounds0led - 5OrbiMed
Star Therapeutics, Leal Therapeutics, Accro Bioscience
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →